Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL dosing cup and one 10-mL oral dosing syringe, Rx Only, Mfd for: ViiV Healthcare Durham, NC, 27701, By: GlaxoSmithKline Durham, NC 27701, NDC 49702-255-37
Published June 12, 2024 · Recall initiated: May 17, 2024
Summary
FDA records drug Class III recall D-0544-2024, published June 12, 2024 and initiated May 17, 2024. Recalling firm: GlaxoSmithKline LLC; Status: Terminated; Reported quantity: 463 Cartons; Lot: Lot #: AG4M, Labeled Expiry date on carton May 2026, correct Exp. Date 04/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
What to do
Voluntary: Firm initiated · Letter
Get an email if TIVICAY has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TIVICAY
- Manufacturer
- GlaxoSmithKline LLC
- Distributor
- Nationwide within the United States
- UPC
- 0349702227132
- Lot
- Lot #: AG4M, Labeled Expiry date on carton May 2026, correct Exp. Date 04/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEstradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila HealthcareJune 12, 2024
- FDAOnce Upon a Farm Organic Plant-Rich Meal, Curried Carrots & Beans, 3.5 oz, packed in single serving flexibleJune 12, 2024
- FDAEstradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila HealthcareJune 12, 2024
- FDACharles Boggini Pink Lemonde; 1 or 5 U.S. GallonsJune 12, 2024
- FDATivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NCJune 1, 2022
- FDATivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NCApril 9, 2014
Questions about this recall
Was Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL dosing cup and one 10-mL oral dosing syringe, Rx Only, Mfd for: ViiV Healthcare Durham, NC, 27701, By: GlaxoSmithKline Durham, NC 27701, NDC 49702-255-37 recalled?
Yes. FDA published recall D-0544-2024 on June 12, 2024. Reported hazard: Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TIVICAY. UPC: 0349702227132.